Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Detroit. Study-provided care at no cost to qualified participants.
Access ovarian cancer specialists in Detroit at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ovarian cancer treatment provided free
This phase II trial studies the side effects of ONC201 and paclitaxel and how well they work in treating patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer that has come back (recurrent), or that does not respond to treatment (refractory). ONC201 is the first in its class of drugs that antagonize some specific cell receptors on cancer cells, leading to their destruction. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop
Sponsor: Ira Winer
Check if you qualify for this ovarian cancer clinical trial in Detroit, MI
If you're searching for ovarian cancer treatment options in Detroit, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Detroit research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.